These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 23780894)
1. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population. Wu D; Jiang H; Gu Q; Zhang D; Li Z Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894 [TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Wei X; Chen D; Lv T Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083 [TBL] [Abstract][Full Text] [Related]
3. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis. Qi Y; Cui L; Song Y; Li N Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232 [TBL] [Abstract][Full Text] [Related]
4. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis. Liu B; Shen T Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436 [TBL] [Abstract][Full Text] [Related]
5. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. Xie T; Wang ZG; Zhang JL; Liu H World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255 [TBL] [Abstract][Full Text] [Related]
6. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk. Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675 [TBL] [Abstract][Full Text] [Related]
7. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis. Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis. Li J; Li Z; Feng L; Guo W; Zhang S Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199 [TBL] [Abstract][Full Text] [Related]
9. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis. Liu DY; Liang HC; Xiao XM Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese. Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604 [TBL] [Abstract][Full Text] [Related]
11. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482 [TBL] [Abstract][Full Text] [Related]
12. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Tian Z; Li YL; Liu JG Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778 [TBL] [Abstract][Full Text] [Related]
13. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk. Wang YD; Zhai WL; Wang HY; Xia XQ Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866 [TBL] [Abstract][Full Text] [Related]
14. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210 [TBL] [Abstract][Full Text] [Related]
15. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis. Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575 [TBL] [Abstract][Full Text] [Related]
16. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis. Duan WH; Zhu ZY; Liu JG; Dong MS; Chen JZ; Liu QD; Xie Y; Sun TY; Gao ZF; Zhou NX Asian Pac J Cancer Prev; 2012; 13(8):3601-4. PubMed ID: 23098440 [TBL] [Abstract][Full Text] [Related]
17. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk. Mao D; Zhang Y; Lu H; Fu X Tumour Biol; 2013 Oct; 34(5):2529-38. PubMed ID: 23857281 [TBL] [Abstract][Full Text] [Related]
18. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis. Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420 [TBL] [Abstract][Full Text] [Related]
19. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women. Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958 [TBL] [Abstract][Full Text] [Related]
20. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Wu K; Su D; Lin K; Luo J; Au WW Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]